http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022020585-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79c69d6fd638eeef6678ba835bd1f21e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
filingDate 2021-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83dd187afad7f841dfccb83257a073af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ad31f51caddc977cb0d04cfba2cf49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8a123745e5fbe340d393ae150518c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa452abde29b91ee02db927f361e384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7cb73f5ff146380b2c01efca20a69e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f45b9bd5e4827abffde5f64d9d950e9
publicationDate 2022-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022020585-A1
titleOfInvention Process for making an isoxazoline compound and intermediate thereof
abstract The present disclosure provides processes for making enantiomerically pure isoxazoline compounds of formula (1), (1). The present disclosure also provides processes for making enantiomerically pure isoxazoline compounds of formula (1) characterized by improving the enantiomeric purity of 3-methyl-5-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]thiophene-2-carboxylic acid by crystallization.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115594645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115504971-A
priorityDate 2020-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014081800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014350261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014206633-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013116236-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017196607-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010070068-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013079407-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014090918-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017176948-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465418746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468235902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467585473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90220102

Total number of triples: 31.